144 related articles for article (PubMed ID: 12730611)
1. Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro.
Thompson KL; Sistare FD
Toxicol Sci; 2003 Aug; 74(2):260-70. PubMed ID: 12730611
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro reporter gene induction assays for use in a rapid prescreen for compound selection to test specificity in the Tg.AC mouse short-term carcinogenicity assay.
Thompson KL; Rosenzweig BA; Tsong Y; Sistare FD
Toxicol Sci; 2000 Sep; 57(1):43-53. PubMed ID: 10966510
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
5. A stable and sensitive testing system for potential carcinogens based on DNA damage-induced gene expression in human HepG2 cell.
Zhang R; Niu Y; Du H; Cao X; Shi D; Hao Q; Zhou Y
Toxicol In Vitro; 2009 Feb; 23(1):158-65. PubMed ID: 19013231
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
7. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.
Thompson KL; Rosenzweig BA; Sistare FD
Toxicol Pathol; 1998; 26(4):548-55. PubMed ID: 9715514
[TBL] [Abstract][Full Text] [Related]
9. The in vivo rodent test systems for assessment of carcinogenic potential.
van der Laan JW; Spindler P
Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
Friedrich A; Olejniczak K
Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
[TBL] [Abstract][Full Text] [Related]
12. Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.
Honchel R; Rosenzweig BA; Thompson KL; Blanchard KT; Furst SM; Stoll RE; Sistare FD
Mol Carcinog; 2001 Feb; 30(2):99-110. PubMed ID: 11241757
[TBL] [Abstract][Full Text] [Related]
13. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
[TBL] [Abstract][Full Text] [Related]
14. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism.
Barsyte-Lovejoy D; Mao DY; Penn LZ
Oncogene; 2004 Apr; 23(19):3481-6. PubMed ID: 15021909
[TBL] [Abstract][Full Text] [Related]
15. DNA-protein interactions in the proximal zeta-globin promoter: identification of novel CCACCC- and CCAAT-binding proteins.
Sabath DE; Koehler KM; Yang WQ; Phan V; Wilson J
Blood Cells Mol Dis; 1998 Jun; 24(2):183-98. PubMed ID: 9642099
[TBL] [Abstract][Full Text] [Related]
16. Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma.
Corazzari M; Lovat PE; Oliverio S; Pearson AD; Piacentini M; Redfern CP
Mol Pharmacol; 2003 Dec; 64(6):1370-8. PubMed ID: 14645667
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
Kirkland D; Speit G
Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
[TBL] [Abstract][Full Text] [Related]
18. Tg.AC genetically altered mouse: assay working group overview of available data.
Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
20. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response.
Fawcett TW; Martindale JL; Guyton KZ; Hai T; Holbrook NJ
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):135-41. PubMed ID: 10085237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
